Lucid Diagnostics Inc. (LUCD) Earnings Call Transcripts

22 earnings calls from May 2022 to June 24, 2026

NasdaqCM US Health Care Health Care Equipment and Supplies

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. (LUCD) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 22 calls on record spanning May 11, 2022 to June 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 22 Lucid Diagnostics Inc. earnings call transcripts on record, spanning May 11, 2022 to June 24, 2026. Based on this history, Lucid Diagnostics Inc. reports quarterly. The most recent call on file is dated June 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LUCD
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
22
First call
May 11, 2022
Most recent
June 24, 2026
Reporting cadence
quarterly
Quarter Date
Shareholder/Analyst Calls Jun 24, 2026 Read transcript
Q1 FY2026 May 14, 2026 Read transcript
Q4 FY2025 Mar 26, 2026 Read transcript
Q3 FY2025 Nov 12, 2025 Read transcript
Special Calls Sep 8, 2025 Read transcript
Q2 FY2025 Aug 13, 2025 Read transcript
Q1 FY2025 May 14, 2025 Read transcript
Q4 FY2024 Mar 24, 2025 Read transcript
Q3 FY2024 Nov 13, 2024 Read transcript
Q2 FY2024 Aug 12, 2024 Read transcript
Shareholder/Analyst Calls Jul 23, 2024 Read transcript
Q1 FY2024 May 13, 2024 Read transcript
Q4 FY2023 Mar 26, 2024 Read transcript
Analyst/Investor Day Dec 13, 2023 Read transcript
Q3 FY2023 Nov 14, 2023 Read transcript
Q2 FY2023 Aug 15, 2023 Read transcript
Shareholder/Analyst Calls Jun 21, 2023 Read transcript
Q4 FY2022 Mar 14, 2023 Read transcript
Q3 FY2022 Nov 14, 2022 Read transcript
Q2 FY2022 Aug 15, 2022 Read transcript
Shareholder/Analyst Calls Jun 21, 2022 Read transcript
Q1 FY2022 May 11, 2022 Read transcript